MARC LUMSDEN: Open Payments
NPI 1598111411 · CAPE GIRARDEAU, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$142 in 8 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $142
Food & beverage: $123Education: $19
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $27 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $24 |
| Exact Sciences Corporation | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| Dexcom, Inc. | 1 | $19 |
| Merck Sharp & Dohme LLC | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
Products named: Kerendia, CAPLYTA, The Cologuard Plus Collection Kit, JARDIANCE, Dexcom G6 Transmitter, GARDASIL 9, REXULTI.
Industry payments across MO — which companies pay providers there.
